QA: Marker Therapeutics Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001094038_2018_Marker_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001094038')"}

Graph

Absolute values for 0001094038, Marker Therapeutics Inc.

  xvar xval
0 AssetsCurrent 5,180,439
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,522,312
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,412,121
9 ResearchAndDevelopmentExpense 5,250,985
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 680,929
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,180,439
1 Liabilities 1,522,312
2 Expenses 11,663,106
3 Revenues 0
4 StockholdersEquity 3,658,127
5 NetIncome -10,982,177
6 ComprehensiveNetIncome -10,982,177
7 BaseVar 9,523,393
8 EconomicCapitalRatio -1.40

Edgar->Model Mapping

Feature Distribution

Change over Time